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ABSTRACT: Ashbya gossypii is a ﬁlamentous fungus that
naturally overproduces riboﬂavin, or vitamin B2. Advances in
genetic and metabolic engineering of A. gossypii have
permitted the switch from industrial chemical synthesis to
the current biotechnological production of this vitamin.
Additionally, A. gossypii is a model organism with one of the
smallest eukaryote genomes being phylogenetically close to
Saccharomyces cerevisiae. It has therefore been used to study
evolutionary aspects of bakers’ yeast. We here reconstructed
the ﬁrst genome scale metabolic model of A. gossypii, iRL766.
The model was validated by biomass growth, riboﬂavin
production and substrate utilization predictions. Gene
essentiality analysis of the A. gossypii model in comparison
with the S. cerevisiae model demonstrated how the whole-
genome duplication event that separates the two species has
led to an even spread of paralogs among all metabolic
pathways. Additionally, iRL766 was used to integrate tran-
scriptomics data from two different growth stages of A.
gossypii, comparing exponential growth to riboﬂavin produc-
tion stages. Both reporter metabolite analysis and in silico
identiﬁcation of transcriptionally regulated enzymes demon-
strated the important involvement of beta-oxidation and the
glyoxylate cycle in riboﬂavin production.
Biotechnol. Bioeng. 2013;9999: 1–9.
 2013 Wiley Periodicals, Inc.
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Introduction
Ashbya gossypii (or Eremothecium gossypii) is a ﬁlamentous
hemiascomycete with unique features which make it a widely
studied organism in both basic research (Wendland and
Walther, 2005) and industrial applications (Kato and
Park, 2012).
Its genome, which has been sequenced and annotated
(Dietrich et al., 2004; Hermida et al., 2005), is one of the
smallest eukaryotic genomes with only 4,718 protein-coding
genes. It is highly similar to the well-studied organism
Saccharomyces cerevisiae and 95% of A. gossypii genes have
homologs in yeast (Dietrich et al., 2004; Fig. 1A). In spite of
this high homology, the S. cerevisiae genome encodes over 800
additional genes (5,570 in total), many of which have
presumably originated from a whole-genome duplication
event (Wolfe and Shields, 1997). While most components are
shared between the two genomes, the life cycles of these two
organisms show important differences, such as the probable
lack of a sexual cycle and the multinucleated hyphae
development in A. gossypii. It has therefore been considered
amodel organism to study theminimal eukaryotic free-living
cell (Finlayson et al., 2011), the event of genome duplication
(Wolfe and Shields, 1997), the pheromone signal cascade and
sexual cycle (Wendland et al., 2011), fungal development and
polarized hyphal growth (Schmitz and Philippsen, 2011) and
to reinvestigate the S. cerevisiae genome (Brachat et al., 2003).
A. gossypii is a natural overproducer of riboﬂavin (vitamin
B2), which animals and humans cannot synthesize. Riboﬂa-
vin is a high value industrial compound used not only in
pharmaceuticals, but also in animal feed additives, cosmetics
and in the food industry (Shi et al., 2009). A. gossypii has
been considered a paradigm of the industry-friendly white
biotechnology and it is nowadays one of the world’s top
producers of riboﬂavin by microbial fermentation (Kato and
Park, 2012; Ledesma-Amaro et al., 2013b; Stahmann et al.,
2000). The availability of the genome sequence and genetic
engineering tools (Wendland et al., 2000) have allowed the
development of metabolic engineering approaches that have
signiﬁcantly increased the vitamin production titer (Jimenez
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et al., 2005, 2008; Park et al., 2011). In addition to its well-
established use in riboﬂavin production, the capabilities of
A. gossypii to produce proteins (Ribeiro et al., 2010, 2013) and
bioethanol from glycerol (Ribeiro et al., 2012) are being
investigated.
Genome-scale metabolic models (GEMs) have become an
important tool in the understanding of metabolic networks
and they have been useful in both the study and the
applications of biological systems (Garcia-Albornoz and
Nielsen, 2013; Kim et al., 2012; Ledesma-Amaro et al.,
2013a). GEMs can serve to describe novel metabolic
networks, ﬁnd essential genes and metabolites, predict
substrate consumption capabilities and aid in re-annotating
genomic information (Costanzo et al., 2010; Ibarra et al.,
2002; Vongsangnak et al., 2008). Additionally, they can be
used as a scaffold to integrate omics experiments and thus
the physiological differences between different conditions
can be analyzed in the context of the metabolic network
(Osterlund et al., 2013). Thirdly, GEMs have been widely
used in the biotechnology ﬁeld for identiﬁcation of metabolic
bottlenecks and novel metabolic engineering targets (Agren
et al., 2013b; Caspeta and Nielsen, 2013; Otero et al., 2013;
Park et al., 2007b).
Here we present the ﬁrst curated genome-scale metabolic
model of the ﬁlamentous fungus A. gossypii, called iRL766.
Along this work iRL766 was validated and its capabilities to
predict biomass growth, riboﬂavin production and substrate
utilization were shown. Gene essentiality was studied in the
context of its own network and of its close relative S. cerevisiae,
enlightening the event of the whole genome duplication. Due
to the industrial interest in this organism for riboﬂavin
production, the biosynthetic pathway of the vitamin within
the model was studied in more detail. Finally the metabolic
network was used to integrate transcriptomics data and
transcriptionally controlled reactions in the transition from a
trophic phase to a riboﬂavin productive phase, representing
possible targets for further strain engineering.
Materials and Methods
Reconstruction of Genome-Scale Metabolic Model
The ﬁrst step in reconstructing the iRL766 model was to
create two draft models using the RAVEN toolbox (Agren
et al., 2013a). The ﬁrst draft model was based on protein
orthology between the S. cerevisiae model iTO977 (Osterlund
et al., 2013) and A. gossypii. For this, homology between the
protein coding sequences of the S. cerevisiae and A. gossypii
genomes were evaluated using bi-directional BLASTp, with
the following cut-offs: E-value <1e30, identity >40% and
alignment length >200 amino acids. All 1-1 orthologs were
included, to capture potential paralogs while ensuring that
only genes that map back to the original gene in the BLASTp
in the opposite direction are included. For the second draft
model the A. gossypii genome was queried using hidden
Markov models (HMMs), which were constructed from
Kyoto Encyclopedia of Genes and Genomes (KEGG)
(Kanehisa et al., 2012) consensus sequences, as described
in (Agren et al., 2013a). The protein sequence of A. gossypii
strain ATCC10895 (http://genolevures.org/) was used for
construction of both draft models. The two draft models were
merged to generate a model representing reactions with and
without homology in S. cerevisiae, using the naming
convention and charge balancing from iTO977. Subsequent-
ly, reactions in the combinedmodel weremanually curated to
assure correctness with respect to reaction stoichiometry,
metabolites and co-factors involved, and to identify gaps in
the metabolic network. Manual curation was performed
using KEGG, MetaCyc (Caspi et al., 2012), Saccharomyces
Genome Database (Cherry et al., 2012), Ashbya Genome
Database (Gattiker et al., 2007), and available literature.
Where A. gossypii speciﬁc knowledge of gene-associations,
metabolic reactions and localization was insufﬁcient, data
from the closely related S. cerevisiae was used.
The biomass equation and ATP for maintenance were
taken from the iTO977 model, as insufﬁcient information is
available from A. gossypii. When oil was used as a carbon
source, the biomass equation was modiﬁed in lipid composi-
tion according to previously reported data (Stahmann et al.,
1994).
All simulations were performed using RAVENand COBRA
toolboxes in Matlab. iRL766 is available in the BioMet
Toolbox (Cvijovic et al., 2010; http://sysbio.se/BioMet/—will
be uploaded upon acceptance of paper).
Constraints-Based Flux Analysis and Simulations
Flux balance analysis was widely performed used in
simulations with the reconstructed GEMs (Park et al.,
2009). Loops were removed from the solution by minimizing
the number of reactions carrying ﬂux. To simulate the trophic
phase, either glucose or oleic acid uptake rates were set, while
biomass productionwas set as objective function. To simulate
the riboﬂavin production phase, the consumption rate of
lipid bodies was set, while riboﬂavin production was set as
Figure 1. Comparison between the A. gossypii and S. cerevisiae genomes and the
iTO977 and iRL766 models. (A) Comparison of the total ORFs in the genomes of S.
cerevisiae (Sc) and A. gossypii (Ag). (B) Comparison of the genes in the yeast model
iTO977 and the Ashbyamodel iRL766, after extensive manual curation. The overlapping
regions of (A) and (B) represent the number of homologous genes. The numbers in bold
are A. gossypii genes with homologs in S. cerevisiae while normal numbers are genes
from S. cerevisiae with homologs in A. gossypii. Asteriks denote approximate value.
2 Biotechnology and Bioengineering, Vol. 9999, No. xxx, 2013
objective function. ATP for maintenance was not considered
in the productive phase since we assumed that this is
produced from different molecular sources (as mutants
unable to consume lipid bodies have the same growth
pattern as wild type (Ledesma-Amaro R., personal commu-
nication). Experimental data were extracted from previous
publications using EasyNData (http://puwer.web.cern.ch/
puwer/EasyNData/).
Gene Essentiality Predictions
In silico evaluation of single gene knock-outs were performed
using the RAVEN toolbox, which takes the presence of iso-
enzymes into account. Lethality was estimated according to a
relative ﬁtness value (f¼mutant growth rate/wild type
growth rate), when f was smaller than the cutoff value
(0.9) the gene was considered essential (Osterlund
et al., 2013). Less strict cutoff values did not drastically
reduce the number of lethal genes (Supplementary File 7).
Two different glucose-based media were used, minimal
media (MM) and rich media (YPD). Minimal media
consisted of the uptake of glucose, ammonium, oxygen,
sulfate and phosphate while YPD media also allowed the
uptake of amino acids and nucleotides.
In Silico Prediction of Carbon and Nitrogen Utilization
Assessment of growth on different carbon sources was
performed by constraining the uptake of each carbon source
individually to 6 C-mol/gCDW/h and maximizing for cell
growth. In silico growth rates were qualitatively compared to
experimental growth rates, and therefore categorized as: no
growth, reduced growth (0.001–0.090 h1) and normal
growth (0.090 h1). Experimental data were classiﬁed in
the same three categories.
Integrative Data Analysis
Normalized microarray dataset E-MEXP-1945 (Gattiker
et al., 2007) was obtained from ArrayExpress (www.ebi.ac.
uk/arrayexpress/). Eighteen and 103 h samples were
analyzed, corresponding to fast growing advanced mycelia
and sporulating mycelia, respectively. The sporulating
mycelia represent the riboﬂavin productive stage, as
sporulation is a process directly correlated to vitamin
production (Stahmann et al., 2001). These data were
integrated in the model iRL766 in order to identify
reporter metabolites and transcriptionally regulated key
enzymes. Reporter metabolites were identiﬁed with R
package Piano (Varemo et al., 2013). A random sampling
algorithmwas applied in order to identify transcriptionally
regulated enzymes (Bordel et al., 2010). Normalized array
data as described above were used as input. The upper and
lower bounds of the exchange ﬂuxes and biomass or
riboﬂavin reactions in iRL766 were constrained according
to experimentally measured ﬂuxes for each condition
(Supplementary ﬁle 5). A set of 500 ﬂux distributions was
generated for each of the considered conditions (Osterlund
et al., 2013). Z-scores were calculated from the two sets of
ﬂux distributions and transformed into probabilities of
change by using the cumulative Gaussian distribution, as
described in Bordel et al. (2010). The values of the
moderated t-statistic from the transcriptomics data were
used to calculate a probabilistic score P for each reaction
representing the probability that the ﬂux and the
transcription are signiﬁcantly changed in the same
direction between the two conditions (cutoff P> 0.9).
Results and Discussion
Reconstruction and Comparative Analysis of the A.
gossypii Metabolic Network
The high sequence similarity between S. cerevisiae and A.
gossypii allowed us to create a ﬁrst draft model using the
yeast model iTO977 as template (Osterlund et al., 2013),
using bi-directional BLASTp, containing 725 genes. No
homologs could be found for 69 genes from iTO977,
corresponding to 76 reactions (Supplementary ﬁle 3).
Among these were reactions involved in biotin and myo-
inositol synthesis, rendering A. gossypii auxotrophic for both
nutrients (Demain, 1972). Additionally, 12 reactions
related to galactose metabolism were absent in A. gossypii,
explaining the incapability of this organism for growth
using galactose as a sole carbon source (Kurtzman
et al., 2011). The use of a S. cerevisiae model as a template
has the disadvantage that the resulting draft model can only
contain genes, and their associated reactions, that have high
sequence identity in A. gossypii. To include the function of A.
gossypii genes that were not represented in the S. cerevisiae
genome, a second draft model was generated based on
similarity with KEGG consensus sequences (Kanehisa
et al., 2012), containing 570 genes. KEGG consensus
sequences provided only 11 A. gossypii genes with no
homologs in S. cerevisiae, responsible for 30 reactions.
Eleven of these reactions were predicted to require
riboﬂavin derivatives, such as ﬂavin mononucleotide
(FMN) or ﬂavin adenine dinucleotide (FAD). These
reactions were added to the ﬁrst draft model, by
transferring the reactions indicated in Supplementary ﬁle
3. Subsequent extensive manual curation of the merged
model generated the model iRL766. iRL766 included 766
genes which were involved in 1,595 reactions, comprising
799 unique metabolites distributed in four different
compartments (cytoplasm, mitochondria, peroxisome,
and extracellular). After manual curation, the number of
unique genes in each model increased to 116 and 69 for the
iTO977 and iRL766 models, respectively. Although the
model has less annotated genes than iTO977 (977 genes)
they still constitute 16.2% of the total open reading frames
of the genome, which is a higher coverage than for the yeast
model (14.8%; Fig. 1B).
While some differences between the models were
observed, it is unlikely that these are sufﬁcient to explain
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the unique properties of each strain but a combination of
these and the unequal regulation at several biological levels.
Riboflavin Biosynthetic Pathway in iRL766
A. gossypii is used on a large-scale in the bioindustry for
riboﬂavin production, often using glucose (Jimenez
et al., 2008) or oils (Park et al., 2011) as carbon source.
The oils used are typically rich in triacylglycerols, predomi-
nantly composed of oleic acid (triolein). To investigate the
production of riboﬂavin from glucose and triolein, FBA was
performed using either carbon source and optimized for
riboﬂavin production (Supplementary ﬁle 4 and Fig. 2).
When glucose was used as sole carbon source, 86 reactions
were involved in riboﬂavin production (Fig. 2A, Supplemen-
tary ﬁle 4). The most important pathways activated in the
model were glycolysis, TCA cycle and oxidative phosphory-
lation, to provide the energy supply, followed by purine
metabolism and pentose phosphate pathway to provide the
precursors GTP and ribulose-5-phosphate respectively, and
ﬁnally riboﬂavin metabolism to synthesize the active vitamin.
When oleic acid was used as carbon source a total of 134
reactions were involved in riboﬂavin synthesis (Fig. 2B,
Supplementary ﬁle 4). The activities of glycolysis and the
pentose phosphate pathway were reduced as fatty acid
degradation was now involved in substrate utilization.
Precursors and riboﬂavin biosynthesis reactions remained
almost invariant during growth on both carbon sources.
These pathways described by iRL766 are in concordance
with previously published data (Park et al., 2007a, 2011;
Stahmann et al., 2000; Sugimoto et al., 2009). Flux variability
analysis was performed to search for alternative solutions
(Supplementary ﬁle 10), and these results adhere to the same
pathways as shown in Figure 2.
Figure 2. Scheme of pathways that carry flux when the riboflavin production phase is simulated in iRL766 when (A) glucose or (B) oleic acid is used as carbon source. FA, fatty
acid; AcCoA, acetyl coA; TCA, tricarboxylic; Glu-6P, glucose-6-phosphate; Ribu-5P, ribulose-5-phosphate.
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Growth Rate and Riboflavin Synthesis Predictions
A. gossypii has two growth stages, a ﬁrst trophic phase, when
cells grow exponentially while riboﬂavin production is
minimal; and a second phase, or productive phase when
cells stop growing and riboﬂavin is overproduced (Mateos
et al., 2006). These two conditions were simulated in the
model, to validate the growth rate and riboﬂavin production
predictions with experimental data (Supplementary ﬁle 5).
The growth predictions on both glucose and triolein were in
good concordance with experimental data (Fig. 3).
There is limited comprehensive data available that can be
used to validate the riboﬂavin productive phase. Firstly, the
carbon source used for the vitamin production has not been
entirely elucidated. In most experimental approaches,
glucose and oils have been exhausted from the media at
the end of the exponential phase. It has been hypothesized
that fatty acids, accumulated as lipid bodies during growth,
are remobilized in the productive phase permitting riboﬂavin
synthesis, supported by microscopy and Nile red staining of
A. gossypii lipid bodies (Lim et al., 2003; Stahmann et al., 1994,
Ledesma-Amaro et al., 2013c). This hypothesis is further
supported by an increase in riboﬂavin synthesis when oils are
used for growth, as A. gossypii accumulates at least twice the
amounts of lipids during the ﬁrst growth phase in these
conditions (Stahmann et al., 1994). Using experimental lipid
bodies consumption rate to constrain the model and
riboﬂavin production as objective function resulted in a
vitamin production rate of 0.0156mmol/gCDW/h, which
was close to the experimental value of 0.0126mmol/gCDW/h
(Stahmann et al., 2001).
In Silico Prediction of Carbon and Nitrogen Utilization
The model was further validated by comparison with
experimental growth data on different carbon and
nitrogen sources (Kurtzman et al., 2011; Ribeiro
et al., 2012; Table I and Supplementary ﬁle 6). Of the 41
tested carbon and nitrogen sources, 39 showed comparable
growth in both model and experiments, while only
D-ribose and D-xylose were identiﬁed in the model as
false positives. While A. gossypii is capable of growth with
D-ribose as sole carbon source, it can do so only in
concentrations below 0.3% due to possible toxicity, which
cannot be predicted by the model (Revuelta, J.L. personal
communication). Regarding D-xylose, it was recently
found that while the machinery for D-xylose consumption
is encoded in the A. gossypii genome, as demonstrated in
iRL766, D-xylose can only be converted to xylitol and not
metabolized further (Ribeiro et al., 2012). Even though the
putative genes for xylose catabolism are present, they
cannot be expressed to sufﬁcient level to ensure growth, as
it is the case in S. cerevisiae (Scalcinati et al., 2012; van Zyl
et al., 1989).
In Silico Analysis of Reaction Essentiality
As A. gossypii has one of the smallest eukaryotic genomes
(Dietrich et al., 2004), iRL766 represents an interesting
platform to study gene essentiality and the minimal set of
reactions to maintain a free-living eukaryotic cell. Addition-
ally, A. gossypii shares high homology to the well-studied yeast
S. cerevisiae, while baker’s yeast encodes 852more genes within
its genome, due to the whole-genome duplication event that
took place in baker’s yeast but not in A. gossypii (Dietrich
et al., 2004). We compared gene essentiality in iRL766 to
iTO977 to investigate this WGD event.
In both models, iTO977 and iRL766, each gene was
knocked out sequentially, and the effect on the speciﬁc
growth rate was examined in minimal and rich media (MM
and YPD). As anticipated, the fraction of essential genes in
the model increased from 18.9% in yeast to 22.5% in A.
gossypii inMM, and from 12.4% in yeast to 14.2% in A. gossypii
in YPD (Fig. 4A). Many of the differences between the two
species can be explained by reactions that are associated with
a single gene in iRL766, whereas they are associated with two
or three different genes in iTO977 (e.g., IMD3-IMD4).
Essential genes for the twomodels were grouped according to
their metabolic function (Fig. 4B, Supplementary ﬁle 7).
Many essential genes were found in lipid metabolism and
oxidative phosphorylation, followed by sugar and nucleotide
metabolism. In MM also many genes in amino acid
metabolism were found to be essential, while the presence
of amino acids in YPD allowed auxotrophs to scavenge amino
acids from the growth medium. There were no major
differences in the spread of essential genes among the
different metabolic pathways in the two models, indicating
that paralogs in S. cerevisiae are evenly spread out over all
metabolic functions.
Figure 3. Comparison between the in silico prediction of specific growth rate with
experimental data. Growth phenotypes were collected from literature and compared
with simulated values when glucose (diamonds) and oils (squares) were used as
carbon sources (Supplementary file 5). Black line represent perfect correlation.
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Integrative Data Analysis
Another powerful use of GEMs is as a scaffold for the analysis
of data fromdifferent biological levels. Focusing on riboﬂavin
production, we analyzed previously published microarray
data (Gattiker et al., 2007) from trophic stage and riboﬂavin
productive stage Even though these microarray data have
extensively been investigated for cell development
(Rischatsch, 2007), the information they carry about
riboﬂavin production has remained unexplored.
Reporter Metabolites
Patterns in the transcriptional responses of the metabolic
network can be revealed by using the network topology from
a GEM (Patil and Nielsen, 2005). We therefore used iRL766
to group genes into sets all coding for enzymes that catalyze
reactions where a speciﬁc metabolite takes part. Enriched or
signiﬁcant gene sets (i.e., reporter metabolites) can be
interpreted as metabolic hotspots or metabolites around
which important transcriptional changes occur (Supple-
mentary ﬁle 8). Among the most signiﬁcant reporter
metabolites were primarily amino acids, likely a consequence
of the protein turnover that is observed between the two
growth stages (Rischatsch, 2007). While riboﬂavin was
among these top metabolites, its precursor cytosolic glycine
appeared as the most reliable reporter metabolite. Glycine
has been described as a key factor in riboﬂavin production
and the increase of this, either by metabolic engineering
approaches or media supplementation leads to riboﬂavin
Table I. Carbon and nitrogen utilization.
Predicted value Experimental value Refs.
Carbon source
Acetate o o Mickelson (1950)
Cellobiose oo o Kurtzman et al. (2011)
Cellulose — — Farries and Bell (1930); Ribeiro et al. (2012)
Citrate o o Kurtzman et al. (2011)
D arabinose — — Kurtzman et al. (2011)
D glucosamine — — Kurtzman et al. (2011)
D mannitol — — Kurtzman et al. (2011)
D ribose oo — Kurtzman et al. (2011)
D xylose oo — Kurtzman et al. (2011); Ribeiro et al. (2012)
D sorbitol oo o Kurtzman et al. (2011)
D gluconate o o Kurtzman et al. (2011)
DL lactate — — Kurtzman et al. (2011)
Erythritol — — Kurtzman et al. (2011)
Ethanol oo o Kurtzman et al. (2011); Mickelson (1950)
Fructose oo oo Farries and Bell (1930)
Galactitiol — — Kurtzman et al. (2011)
Galactose — — Kurtzman et al. (2011)
Glucose oo oo Kurtzman et al. (2011); Ribeiro et al. (2012)
Glycerol oo oo Kurtzman et al. (2011); Ribeiro et al. (2012)
Hexadecane — — Kurtzman et al. (2011)
Inulin — — Kurtzman et al. (2011)
L arabinose — — Kurtzman et al. (2011); Ribeiro et al. (2012)
L rhamnose — — Kurtzman et al. (2011)
L sorbose — — Kurtzman et al. (2011)
Lactose — — Farries and Bell (1930); Kurtzman et al. (2011); Mickelson (1950)
Maltose oo o Kurtzman et al. (2011)
Melezitose — — Kurtzman et al. (2011)
Melibiose — — Kurtzman et al. (2011)
Methanol — — Kurtzman et al. (2011)
Methyl-alpha-D glucoside — — Kurtzman et al. (2011)
Myoinositol — — Kurtzman et al. (2011)
NADglucosamine — — Kurtzman et al. (2011)
Pyruvate o o Mickelson (1950)
Raffinose o oo Kurtzman et al. (2011)
Ribitol — — Kurtzman et al. (2011)
Starch oo oo Ribeiro et al. (2012)
Succinate o o Kurtzman et al. (2011)
Sucrose oo oo Kurtzman et al. (2011)
Trehalose oo oo Kurtzman et al. (2011)
Nitrogen source
NH4 oo oo Ribeiro et al. (2012)
Nitrate — — Kurtzman et al. (2011); Ribeiro et al. (2012)
Comparison of in silico (predicted) and in vivo (experimenal) growth on different carbon and nitrogen sources. — represents no growth; o represents
reduced growth; while oo represents unimpaired growth, compared to growth on glucose (Supplementary ﬁle 6).
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overproduction (Monschau et al., 1998; Schlupen
et al., 2003). Glyoxylate and the vast presence of fatty acids
derivatives as reporter metabolites supported the proposed
mechanism for riboﬂavin production through beta-oxida-
tion of lipid bodies and the glyoxylate cycle. Also other
intermediates in riboﬂavin biosynthesis appeared at high
positions in the up regulated reporter metabolite list such as
4-(1-D-ribitylamino)-5-amino-2,6-dihydroxypyrimidine,
6,7-dimethyl-8-(1-D-ribityl)lumazine or 3,4-dihydroxy-2-
butanone 4-phosphate.
Identification of Transcriptionally Regulated Enzymes
Genetic engineering of A. gossypii has allowed to increase the
production of riboﬂavin to an industrial level (Kato and
Park, 2012). Enzymes that correlate in expression levels and
metabolic ﬂuxes are potential targets for overexpression, in
an attempt to direct the metabolic ﬂux towards a desired
product. We identiﬁed what changes in metabolic ﬂuxes in
response to the riboﬂavin production phase are transcrip-
tionally regulated. The transcriptomics dataset is described
above.
For the metabolic ﬂuxes, a space of feasible ﬂux
distributions was deﬁned by constraining the model by a
small set of experimental metabolic ﬂuxes and appropriate
objective functions for each condition. A collection of
possible ﬂux distributions was calculated using a random
sampling algorithm (Bordel et al., 2010). Flux distributions
from the two conditions were compared and probability
scores were calculated to identify the signiﬁcance of the
observed changes. The probability score of the change in
metabolic ﬂux was compared to the probability score of a
transcriptional change, obtained from the microarray data-
set. The reactions with a probability score higher than 0.9, as
calculated by the random sampling algorithm (Bordel
et al., 2010), present both changes in the same direction.
Statistics for both up- and down-regulated reactions were
calculated (Supplementary ﬁle 9).
In total, 38 reactions demonstrated correlated increases in
both transcript levels and metabolic ﬂuxes; these reactions
were transcriptionally up-regulated. Four of those reactions
were part of the riboﬂavin synthetic pathway: RIB2, RIB3,
RIB4, and RIB5 (Fig. 5). Other up-regulated reactions were
involved in beta-oxidation (e.g., POX and FOX2) and
gluconeogenesis (FBP1, PCK1), supporting the hypothesis
of lipid bodies consumption in the riboﬂavin productive
phase. Almost all other up-regulated reactions were involved
in extracellular uptake of amino acids and nucleosides. A.
gossypii can suffer autolysis in the latest phases of its life cycle:
some cells can lyse in order to supply nutrients to the
remaining cells which continue their riboﬂavin overproduc-
tion and sporulation (Stahmann et al., 2000). This explains
the up-regulation of amino acid and nucleoside permeases in
this growth phase. All the genes involved in the reactions
identiﬁed as up-regulated are potential candidates for
overexpression in order to increase riboﬂavin production.
While some, such as the RIB genes, are more obvious,
especially the genes of beta-oxidation and gluconeogenesis
Figure 4. Gene essentiality was investigated in both models iRL766 and iTO977 by knocking out individual genes and assessing their growth rate. Whole models comparison
where (A) the fraction of essential genes over all genes in the model, and (B) metabolic groups of these essential genes are shown. MM, minimal media: YPD, rich media.
Figure 5. Transcriptionally controlled reactions (reactions where the change in
flux correlate with change in expression of the involved gene) in riboflavin synthesis.
Gene in squares are responsible for an up-regulated reaction identified by the random
sampling algorithm when comparing trophic phase and riboflavin productive phase.
UnkPh (unknown phosphatase), Ribu5P (ribulose 5 phosphate), DHBP (3,4-dihydroxy-2-
butanone 4-phosphate), DARPP (2,5-diamino-6-hydroxy-4-(50-phosphoribosylamino)-
pyrimidine), DArPP (2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 50-phosphate),
ArPP (5-amino-6-(50-phosphoribitylamino)uracil), ArP (4-(1-D-ribitylamino)-5-amino-
2,6-dihydroxypyrimidine), DRL (6,7-dimethyl-8-(1-D-ribityl)lumazine).
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would require further investigation to elucidate whether the
sole overexpression of these genes lead to some increase in the
vitamin titer and experimental data must be done to conﬁrm
this.
A larger number of reactions, 127, were transcriptionally
down-regulated and many of those are related to biomass
formation. Interestingly, many reactions from purine biosyn-
thesis were down-regulated, despite this pathway’s involve-
ment in the supply of GTP for riboﬂavin production. This has
been previously described for some of the genes of purine
biosynthesis, such as ADE4 (Mateos et al., 2006), indicating
that either the nucleotides have been synthetized in excess
during the trophic phase or the nucleotides/nucleosides from
partially broken mycelia are taken up from the environment
using the up-regulated permeases. Additionally, down-
regulation also prevents riboﬂavin consumption by riboﬂavin
kinase (FMN1) and glycine degradation by SHM2 and GCV.
Indeed the disruption of SHM2 in A. gossypii leads to an
accumulation of riboﬂavin (Schlupen et al., 2003) and both
SHM2 and ADE4 have been identiﬁed as down-regulated by
the transcription factor BAS1 (Mateos et al., 2006).
Conclusions
In this study, we reconstructed and validated the ﬁrst
manually curated genome-scale model of A. gossypii, iRL766,
with particular focus on the riboﬂavin production by this
fungus. The model is in good concordance with existing
experimental data on the pathways involved in riboﬂavin
production, growth rate and the use of different carbon
sources. Subsequently, the curated GEM was used to analyze
gene essentiality, particularly in comparison to the S. cerevisiae
GEM iTO977. The increased number of predicted essential
genes in iRL766 could be transcribed to the whole genome
duplication event that has occurred in S. cerevisiae but not in A.
gossypii. Categorizing the predicted essential genes in
metabolic pathways indicated that this event has led to an
even spread of paralogs among all metabolic pathways. This is
in agreement with the proposed rationale of gene duplication,
where duplicated genes do not belong to any particular
dominated function and do not occur more frequently in
essential genes, but often overlap functional roles (Kuepfer
et al., 2005).
Subsequently, the model was used as a scaffold to analyze
microarray data to investigate the transcriptional changes
related to riboﬂavin production. Reporter metabolite analysis
indicated glycine, glyoxylate, and fatty acids as important
metabolic hot spots, together with the anticipated riboﬂavin.
A random sampling algorithm was employed to identify
transcriptionally regulated reactions in the GEM. Together
with the anticipated RIB genes, also beta oxidation and
gluconeogenesis were transcriptionally up-regulated. Addi-
tionally observed important reporter metabolites and
transcriptionally regulated reactions were supported by
previous publications. This underwrites the validity of the
model and indicates how it can be used in future approaches
not only for overproduction of riboﬂavin, but also other
vitamins, proteins, or lipids, as well as it can be used to
improve our knowledge of this organism.
R. L.-A. was recipient of an FPU predoctoral fellowship from the
Ministerio de Educación, Cultura y Deporte and an EMBO short-term
fellowship.
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